Collegium Pharmaceutical(DE:354)
€22.00+0.60 (+2.80%)
DE:354
Collegium Pharmaceutical stock forecast
€22.00
At close:+0.60 (+2.80%)
Collegium Pharmaceutical (354) Stock Forecast & Price Target
0 Followers
354 Analyst Ratings
Strong Buy
5Buy1Hold0Sell
Based on 6 analysts giving stock ratings to Collegium Pharmaceutical in the past 3 months
354 Stock 12 Month Forecast
Average Price Target
€41.63▲(89.22% Upside)Based on 6 Wall Street analysts offering 12 month price targets for Collegium Pharmaceutical in the last 3 months. The average price target is EUR 41.63 with a high forecast of EUR 53.52 and a low forecast of EUR 24.98. The average price target represents a 89.22% change from the last price of EUR 22.00.
Past 12 Months12 Month ForecastJan2026Oct2026
High€53.52
Average€41.63
Low€24.98
Highest Price TargetHighest€53.52Average Price Target€41.63Lowest Price TargetLowest€24.98
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Brandon Folkes | H.C. Wainwright | €53.52 | buy | 143.29%Upside | Reiterated | 11/06/26 | ||
| David Amsellem | Piper Sandler | €38.36→€24.98 | hold | 13.53%Upside | Reiterated | 11/06/26 | ||
| Alexander Xenakis | Truist Financial | €43.71 | buy | 98.68%Upside | Reiterated | 11/06/26 | ||
| Jenna Davidner | Barclays | €42.82 | buy | 94.63%Upside | Reiterated | 10/15/26 | ||
| Les Sulewski | Oppenheimer | €44.60 | buy | 102.74%Upside | Reiterated | 10/09/26 | ||
| Daniel Clark | Leerink Partners | €40.14 | buy | 82.46%Upside | Initiated | 09/09/26 | ||
| Serge Belanger | Needham | €49.95→€41.03 | buy | 86.52%Upside | Reiterated | 08/06/26 | ||
 Unknown AnalystNot Ranked | Jefferies | €45.49 | buy | 106.79%Upside | Reiterated | 03/20/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Brandon FolkesH.C. Wainwright | BuyReiterated€53.52 | 11/06/26 | 143.29%Upside | ||
| David AmsellemPiper Sandler | HoldReiterated€38.36→€24.98 | 11/06/26 | 13.53%Upside | ||
| Alexander XenakisTruist Financial | BuyReiterated€43.71 | 11/06/26 | 98.68%Upside | ||
| Jenna DavidnerBarclays | BuyReiterated€42.82 | 10/15/26 | 94.63%Upside | ||
| Les SulewskiOppenheimer | BuyReiterated€44.60 | 10/09/26 | 102.74%Upside | ||
| Daniel ClarkLeerink Partners | BuyInitiated€40.14 | 09/09/26 | 82.46%Upside | ||
| Serge BelangerNeedham | BuyReiterated€49.95→€41.03 | 08/06/26 | 86.52%Upside | ||
| Unknown AnalystJefferiesNot Ranked | BuyReiterated€45.49 | 03/20/26 | 106.79%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Collegium Pharmaceutical
3 Months
Success Rate11/20 ratings generated profit
55%
Average Return
+6.31%
Copying Les Sulewski's trades and holding each position for 3 Months would result in 55.00% of your transactions generating a profit, with an average return of +6.31% per trade.
1 Year
Success Rate12/24 ratings generated profit
50%
Average Return
+5.60%
Copying Serge Belanger's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.60% per trade.
2 Years
Success Rate12/26 ratings generated profit
46%
Average Return
+1.64%
Copying Brandon Folkes's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of +1.64% per trade.
354 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 8 | 9 | 8 |
| Buy | 3 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 5 | 9 | 10 | 9 |
In the current month, 354 has received 8 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 354 average Analyst price target in the past 3 months is 41.63.
354 Financial Forecast
High€1.84
Consensus€1.72
Low€1.58
354 Earnings Forecast
Next quarter’s earnings estimate for 354 is EUR 1.72 with a range of EUR 1.58 to EUR 1.84. The previous quarter’s EPS was EUR 1.75. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€201M
Consensus€199M
Low€194M
354 Sales Forecast
Next quarter’s sales forecast for 354 is EUR 198.95M with a range of EUR 193.75M to EUR 200.83M. The previous quarter’s sales results were EUR 193.70M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
354 Stock Forecast FAQ
What is DE:354’s average 12-month price target, according to analysts?
Based on analyst ratings, Collegium Pharmaceutical’s 12-month average price target is €41.63.
What is DE:354’s upside potential, based on the analysts’ average price target?
Collegium Pharmaceutical has 89.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Collegium Pharmaceutical a Buy, Sell or Hold?
Collegium Pharmaceutical has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is Collegium Pharmaceutical’s share price target?
The average share price target for Collegium Pharmaceutical is €41.63. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €53.52, and the lowest forecast is €24.98. The average share price target represents a 89.22% increase from the current price of €22.
What do analysts say about Collegium Pharmaceutical?
Collegium Pharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of Collegium Pharmaceutical?
To buy shares of DE:354, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
